SI2146714T1 - Uporaba 4-ciklopropilmetoksi-N-(3,5-dikloro-1-oksido-piridin-4-il)-5-(metoksi) priridin-2-karboksamida za zdravljenje motoričnih motenj, povezanih s Parkinsonovo boleznijo - Google Patents

Uporaba 4-ciklopropilmetoksi-N-(3,5-dikloro-1-oksido-piridin-4-il)-5-(metoksi) priridin-2-karboksamida za zdravljenje motoričnih motenj, povezanih s Parkinsonovo boleznijo

Info

Publication number
SI2146714T1
SI2146714T1 SI200830357T SI200830357T SI2146714T1 SI 2146714 T1 SI2146714 T1 SI 2146714T1 SI 200830357 T SI200830357 T SI 200830357T SI 200830357 T SI200830357 T SI 200830357T SI 2146714 T1 SI2146714 T1 SI 2146714T1
Authority
SI
Slovenia
Prior art keywords
oxidopyridin
cyclopropylmethoxy
carboxamide
parkinson
dichloro
Prior art date
Application number
SI200830357T
Other languages
English (en)
Inventor
Philippe Delay-Goyet
Claire Delgorge
Christine Menet
Gilles Poughon
Christine Ravinet-Trillou
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of SI2146714T1 publication Critical patent/SI2146714T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
SI200830357T 2007-04-19 2008-04-16 Uporaba 4-ciklopropilmetoksi-N-(3,5-dikloro-1-oksido-piridin-4-il)-5-(metoksi) priridin-2-karboksamida za zdravljenje motoričnih motenj, povezanih s Parkinsonovo boleznijo SI2146714T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0702853A FR2915100B1 (fr) 2007-04-19 2007-04-19 Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxalide pour le traitement des desordres moteurs lies a la maladie de parkinson
PCT/FR2008/000534 WO2008145841A1 (fr) 2007-04-19 2008-04-16 Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des desordres moteurs lies a la maladie de parkinson
EP08787963A EP2146714B1 (fr) 2007-04-19 2008-04-16 Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des desordres moteurs lies a la maladie de parkinson

Publications (1)

Publication Number Publication Date
SI2146714T1 true SI2146714T1 (sl) 2011-10-28

Family

ID=38712405

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200830357T SI2146714T1 (sl) 2007-04-19 2008-04-16 Uporaba 4-ciklopropilmetoksi-N-(3,5-dikloro-1-oksido-piridin-4-il)-5-(metoksi) priridin-2-karboksamida za zdravljenje motoričnih motenj, povezanih s Parkinsonovo boleznijo

Country Status (34)

Country Link
US (1) US20100130554A1 (sl)
EP (1) EP2146714B1 (sl)
JP (1) JP5386478B2 (sl)
KR (2) KR101503942B1 (sl)
CN (1) CN101663035B (sl)
AR (1) AR066108A1 (sl)
AT (1) ATE513548T1 (sl)
AU (1) AU2008257322B2 (sl)
BR (1) BRPI0810444A2 (sl)
CA (1) CA2684174C (sl)
CL (1) CL2008001136A1 (sl)
CY (1) CY1111840T1 (sl)
DK (1) DK2146714T3 (sl)
EA (1) EA019194B1 (sl)
ES (1) ES2367408T3 (sl)
FR (1) FR2915100B1 (sl)
HK (1) HK1141725A1 (sl)
HR (1) HRP20110666T1 (sl)
IL (1) IL201448A (sl)
JO (1) JO2678B1 (sl)
MA (1) MA31367B1 (sl)
ME (1) ME00935B (sl)
MX (1) MX2009011284A (sl)
MY (1) MY148092A (sl)
NZ (1) NZ580482A (sl)
PA (1) PA8776801A1 (sl)
PL (1) PL2146714T3 (sl)
PT (1) PT2146714E (sl)
RS (1) RS51869B (sl)
SI (1) SI2146714T1 (sl)
TW (1) TWI439269B (sl)
UY (1) UY31035A1 (sl)
WO (1) WO2008145841A1 (sl)
ZA (1) ZA200907251B (sl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015006807A (es) * 2012-11-28 2016-01-14 Sanofi Sa Metodo de preparacion de formas cristalinas de la 4-(ciclopropilmetoxi)-n-(3,5-dicloro-1-oxidopiridin-4-il)-5-metox ipiridin-2-carboxamida y sus formas cristalinas.
US9624100B2 (en) 2014-06-12 2017-04-18 Apple Inc. Micro pick up array pivot mount with integrated strain sensing elements

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193926A (en) * 1974-03-20 1980-03-18 Schering Aktiengesellschaft 4-(Polyalkoxy phenyl)-2-pyrrolidones
ATE218549T1 (de) * 1993-07-28 2002-06-15 Aventis Pharma Ltd Verbindungen als pde iv und tnf inhibitoren
US6177077B1 (en) * 1999-02-24 2001-01-23 Edward L. Tobinick TNT inhibitors for the treatment of neurological disorders
WO2001047915A1 (en) * 1999-12-23 2001-07-05 Icos Corporation Cyclic amp-specific phosphodiesterase inhibitors
HUP0600103A2 (en) * 2001-03-02 2006-06-28 Bristol Myers Squibb Co Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
WO2004005258A1 (en) * 2002-07-02 2004-01-15 Merck Frosst Canada & Co. Di-aryl-substituted-ethane pyridone pde4 inhibitors
CA2518513C (en) * 2003-03-12 2014-05-20 Celgene Corporation N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses
AU2006257863A1 (en) * 2005-06-10 2006-12-21 F. Hoffmann-La Roche Ag Trisubstituted amines as phosphodiesterase 4 inhibitors
US20070021451A1 (en) * 2005-07-20 2007-01-25 Hamamatsu University School Of Medicine Method for preventing or treating neurologic damage after spinal cord injury

Also Published As

Publication number Publication date
EA019194B1 (ru) 2014-01-30
JP5386478B2 (ja) 2014-01-15
EA200970970A1 (ru) 2010-02-26
IL201448A0 (en) 2010-05-31
KR101503942B1 (ko) 2015-03-18
PA8776801A1 (es) 2008-11-19
CL2008001136A1 (es) 2009-01-16
CY1111840T1 (el) 2015-10-07
RS51869B (en) 2012-02-29
PT2146714E (pt) 2011-09-02
CA2684174C (fr) 2014-02-25
ES2367408T3 (es) 2011-11-03
FR2915100B1 (fr) 2009-06-05
US20100130554A1 (en) 2010-05-27
AR066108A1 (es) 2009-07-22
FR2915100A1 (fr) 2008-10-24
CN101663035B (zh) 2012-06-20
PL2146714T3 (pl) 2011-10-31
ZA200907251B (en) 2011-04-28
MY148092A (en) 2013-02-28
HK1141725A1 (sl) 2010-11-19
CA2684174A1 (fr) 2008-12-04
JO2678B1 (en) 2013-03-03
KR20150004885A (ko) 2015-01-13
MA31367B1 (fr) 2010-05-03
CN101663035A (zh) 2010-03-03
EP2146714B1 (fr) 2011-06-22
BRPI0810444A2 (pt) 2016-05-31
DK2146714T3 (da) 2011-10-10
AU2008257322A1 (en) 2008-12-04
KR20090130059A (ko) 2009-12-17
JP2010524906A (ja) 2010-07-22
ATE513548T1 (de) 2011-07-15
IL201448A (en) 2014-08-31
UY31035A1 (es) 2008-11-28
EP2146714A1 (fr) 2010-01-27
AU2008257322B2 (en) 2013-06-13
TW200911247A (en) 2009-03-16
HRP20110666T1 (hr) 2011-10-31
MX2009011284A (es) 2009-11-02
WO2008145841A1 (fr) 2008-12-04
NZ580482A (en) 2011-10-28
ME00935B (me) 2012-06-20
TWI439269B (zh) 2014-06-01

Similar Documents

Publication Publication Date Title
ZA200909191B (en) Catecholamine derivatives useful for the treatment of parkinson's disease
BRPI0818799A2 (pt) Composições para o tratamento da doença de parkinson
HK1166983A1 (zh) 包含用於治療疾病或紊亂的化合物的固體形式，其組合物，及其用途
EP2166837A4 (en) DRUG COMBINATION USEFUL FOR THE TREATMENT OF SKIN DISORDERS
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
EP2120938A4 (en) IMIDAZOPYRIDINE ANALOGUE AS CB2 RECEPTOR MODULATORS FOR THE TREATMENT OF PAIN, RESPIRATORY AND NON-RESPIRATORY DISEASES
SI2229369T1 (sl) Derivati 6,7-dialkoksi kinazolina, uporabni za zdravljenje motenj, povezanih z rakom
AU2008233088A8 (en) Calcimimetic compounds for use in the treatment of bowel disorders
HK1146221A1 (en) Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders
EP2214488A4 (en) COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE AND RELATED DISORDERS
IL201451A0 (en) Use of 4 - cyclopropylmethoxy - n - (3, 5 - dichloro - 1 - oxidopyridin - 4 - yl) - 5 - (methoxy) pyridine - 2 - carboxamide for the treatment of spinal cord traumas
PL2146714T3 (pl) Zastosowanie 4-cyklopropylometoksy-n-(3,5-dichloro-1-tlenek-pirydyn-4-ylo)-5-(metoksy)pirydyno-2-karboksyamidu do leczenia zaburzeń ruchowych związanych z chorobą parkinsona
GB0710277D0 (en) Use of antivirals in the treatment of medical disorders
BRPI0714307A2 (pt) Uso de benzamidas trifluormetil-substituídas no tratamento de distúrbios neurológicos
HK1129112A1 (en) 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders
IL201447A0 (en) Use of 4 - cyclopropylmethoxy - n - (3, 5 - dichloro - 1 - oxidopyridin - 4 - yl) - 5 - (methoxy) pyridine - 2 - carboxamide for the treatment of cranial traumas
EP2285365A4 (en) USE OF A COMPOSITION COMPRISING AT LEAST ONE BETABILITY TREATMENT FOR THE TREATMENT OF SLEEP DISORDERS
IL194275A0 (en) Use of digitalis-like compounds in the treatment of affective disorders